Chronic diseases incur a significant socio-economic cost to both patients and the health care system. Physicians must continuously monitor and modify therapies to best meet the patients’ changing requirements, often requiring regular health care visits for specialized testing. Hydroxychloroquine (HCQ) is a disease-modifying antirheumatic drug often prescribed to patients with chronic inflammatory diseases such as […]
Read More